Post Operative Nausea & Vomiting: Difference between revisions

From PedsAnesthesiaNet
Jump to navigation Jump to search
No edit summary
No edit summary
Line 52: Line 52:
Bailard N, Rebello E. Aprepitant and fosaprepitant decrease the effectiveness of hormonal contraceptives. Br J Clin Pharmacol. 2018 Mar; 84(3): 602-603. PMID: 29266364
Bailard N, Rebello E. Aprepitant and fosaprepitant decrease the effectiveness of hormonal contraceptives. Br J Clin Pharmacol. 2018 Mar; 84(3): 602-603. PMID: 29266364


Patel P, Leeder JS, Piquette-Miller M, Dupuis LL. Aprepitant and fosaprepitant drug interactions: a systematic review. Br J Clin Pharmacol. 2017 Oct; 83(10): 2148-2162. PMID: 28470980
[https://pubmed.ncbi.nlm.nih.gov/28470980/  Aprepitant and fosaprepitant drug interactions: a systematic review]

Revision as of 02:13, 28 November 2023

This is a Stub Notice. This page has not been completed. You can work on this page by signing in and going to the Edit tab. Thanks for helping to make PedsAnesthesia.Net Wiki useful.

Go to the Main Page to see the Topic Outline.

Go to the Generalized Suggested Outline for information on case-specific details for each page.

Go to the Test Page for examples on how to use references in the page.


Relevant Article Depot:


PONV

Postoperative nausea and vomiting in pediatric anesthesia

Is infusion of subhypnotic propofol as effective as dexamethasone in prevention of postoperative nausea and vomiting related to laparoscopic cholecystectomy? A randomized controlled trial

Subhypnotic propofol infusion plus dexamethasone is more effective than dexamethasone alone for the prevention of vomiting in children after tonsillectomy

The cellular mechanisms of the antiemetic action of dexamethasone and related glucocorticoids against vomiting

Fourth Consensus Guidelines for the Management of Postoperative Nausea and Vomiting Erratum

Postoperative Nausea and Vomiting in Pediatric Patients

An update on the management of PONV in a pediatric patient

Test Your Knowledge:Risk factors for PONV

APONVIE From Heron Therapeutics Gains FDA Approval for PONV

WFSA Tutorial 479: Paediatric Postoperative Vomiting

Rescue Treatment of Postoperative Nausea and Vomiting: A Systematic Review of Current Clinical Evidence

Supplemental perioperative intravenous crystalloids for postoperative nausea and vomiting

Aromatherapy for treatment of postoperative nausea and vomiting

Inhaled Isopropyl Alcohol Superior to Oral Ondansetron as an Antiemetic

Stimulation of the wrist acupuncture point PC6 for preventing postoperative nausea and vomiting

The FDA Droperidol Warning: Is It Justified?

Dopamine-Antagonist Antiemetics in PONV Management: Entering a New Era?

Clinical Use of the Pictorial Baxter Retching Faces Scale for the Measurement of Postoperative Nausea in Children

Antiemetic Administration and Its Association with Race: A Retrospective Cohort Study

Factorial Trial of Six Interventions for the Prevention of Postoperative Nausea and Vomiting

Roberts GW, Bekker TB, Carlsen HH, Moffatt CH, Slattery PJ, McClure AF. Postoperative nausea and vomiting are strongly influenced by postoperative opioid use in a dose-related manner. Anesth Analg. 2005 Nov; 101(5): 1343-8. PMID: 16243992

Prophylaxis for pediatric postoperative nausea and vomiting: a scoping review of clinical trials

Salman FT, DiCristina C, Chain A, Afzal AS. Pharmacokinetics and pharmacodynamics of aprepitant for the prevention of postoperative nausea and vomiting in pediatric subjects. J Pediatr Surg. 2019 Jul; 54(7): 1384-1390. PMID: 30381138

Bailard N, Rebello E. Aprepitant and fosaprepitant decrease the effectiveness of hormonal contraceptives. Br J Clin Pharmacol. 2018 Mar; 84(3): 602-603. PMID: 29266364

Aprepitant and fosaprepitant drug interactions: a systematic review